Skip to main content

Table 1 Analysis of p53 mutation and IGF2 gene imprinting in human tumor cells

From: Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system

Cell lines p53 status IGF2 Imprinting
GES-1 Wild type MOI
HCT116 Wild type MOI
HCT8 Wild type LOI
HT29 Mutation LOI
  1. LOI: Loss of IGF2 imprinting; MOI: Maintenance of IGF2 imprinting.